Upgrade to SI Premium - Free Trial

Cantor Fitzgerald Starts AbCellera Biologics (ABCL) at Overweight

May 5, 2026 6:08 AM
Cantor Fitzgerald analyst Steve Seedhouse initiates coverage on AbCellera Biologics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

New Coverage